The health of Aboriginal and Torres Strait Islander populations is a major issue in Australia. In the area of infectious diseases, these populations experience a disproportionate burden of disease.
According to the latest statistics, HIV notification rates have doubled among Aboriginal and Torres Strait Islander men over the past five years and rates of chlamydia, gonorrhoea and infectious syphilis are 3, 10 and 6 times greater than the non-Indigenous population.
Aboriginal people are a priority population for Kirby Institute research. Our Aboriginal health research includes the evaluation of viral hepatitis, HIV and STI interventions in Aboriginal Community Controlled Health Services, prisoner health surveys, mathematically modelling, literature reviews, quality improvement, national surveillance of STIs and blood-borne viruses, and policy development.
Our researchers are conducting trials of chlamydia and gonorrhoea tests that give immediate results to people in remote Aboriginal communities. The research project, called Test Treat ANd GO—or TTANGO—has shown that these tests are both effective and acceptable for people in remote Aboriginal communities.
We are involved in Centre for Research Excellence in Aboriginal Sexual Health and Blood-Borne viruses. We work collaboratively to achieve positive health outcomes for individuals and communities. We have strong partnerships with Aboriginal and Torres Strait Islander organisations and services.
Our programs that work in this area
- Aboriginal and Torres Strait Islander Health
- Biostatistics and Databases
- HIV Epidemiology and Prevention
- Justice Health
- Public Health Interventions
- Sexual Health
- Surveillance and Evaluation
- Viral Hepatitis Clinical Research
- Viral Hepatitis Epidemiology and Prevention